The Dana-Farber Cancer Institute (DFCI) PGY2 Pain Management and Palliative Care residency is a structured, 1-year postgraduate educational and training experience that fosters the development of advanced knowledge and skill in the delivery of pharmaceutical services to patients with acute and chronic pain conditions and/or advanced life-threatening illness. The residency consists of learning experiences in key areas of clinical pain management and palliative care practice, including inpatient and outpatient palliative care, hospice, inpatient and outpatient specialized pain management and pain management in the primary care setting. Primary clinical sites include: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and MCPHS University. Didactic and experiential learning is enhanced through the Harvard Interprofessional Palliative Care Fellowship Program.
The Harvard Interprofessional Palliative Care Fellowship Program includes medical, nursing, pharmacy and social work fellows in both adult and pediatric palliative care. The pharmacy resident is fully integrated into this fellowship program which offers a unique opportunity with didactic and experiential learning that are geared toward the healthcare professional working with and interdisciplinary team.
The fundamental goal of the residency is to provide training so that pharmacists develop excellent clinical and administrative knowledge, patient care and communication skills and quality improvement or research experience to become proficient clinical pain management and palliative care pharmacy practitioners and leaders.
Applicants must expect to complete an ASHP accredited PGY-1 pharmacy residency and be licensed in the state of Massachusetts by summer of 2019. Application requirements: Complete PhORCAS application by Thursday, January 2, 2020.
PPS interviews will be conducted on Sunday, December 8th through Wednesday December 11th. For consideration for an interview, please send a message through the PPS messenger. Priority will be given to candidates who submit interview requests by Friday, November 15th. DFCI will also be meeting candidates on Monday afternoon December 9th during the Residency Showcase from 1-4 pm.
Internal Number: 002
About Dana-Farber Cancer Institute
Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.
The mission of the Dana-Farber Cancer Institute Pharmacy Department is to provide expert pharmaceutical care to our patients as an integral member of the health care team. The Pharmacy Department also provides clinical and technical training to pharmacy students and pharmacy residents.